Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.
This study has been completed.
Study NCT00677105 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on May 8, 2008. Last Updated on September 14, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Immune System Diseases
Neoplasms by Histologic Type
Interventions listed in this trial
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Janssen Pharmaceutica N.V., Belgium
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers